Statement Of Financial Position [Abstract]

ABIONYX Pharma - Filing #2821124

Concept As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-01-01
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-01-01
As at
2019-01-01
As at
2019-01-01
As at
2019-01-01
As at
2019-01-01
As at
2019-01-01
As at
2019-01-01
Statement of financial position [abstract]
Assets [abstract]
Non-current assets [abstract]
Property, plant and equipment
91,000 EUR
10,000 EUR
Right-of-use assets
24,000 EUR
83,000 EUR
Deferred tax assets
0 EUR
0 EUR
Non-current assets
255,000 EUR
124,000 EUR
Current assets [abstract]
Current inventories
0 EUR
0 EUR
Cash and cash equivalents
9 154 EUR
8 331 EUR
8 331 EUR
11 457 EUR
Current assets
10 033 EUR
10 125 EUR
Assets
10 288 EUR
10 249 EUR
Equity and liabilities [abstract]
Equity [abstract]
Issued capital
1 232 EUR
1 097 EUR
Share premium
170 322 EUR
168 619 EUR
Equity
176 730 EUR
1 232 EUR
30,000 EUR
39,000 EUR
11 797 EUR
170 322 EUR
6 629 EUR
11 699 EUR
25,000 EUR
92,000 EUR
168 621 EUR
6 666 EUR
174 818 EUR
1 097 EUR
11 601 EUR
25,000 EUR
947,000 EUR
167 832 EUR
176 595 EUR
3 838 EUR
78,000 EUR
Liabilities [abstract]
Non-current liabilities [abstract]
Non-current provisions [abstract]
Non-current provisions
61,000 EUR
94,000 EUR
Deferred tax liabilities
0 EUR
0 EUR
Non-current liabilities
61,000 EUR
117,000 EUR
Current liabilities [abstract]
Current provisions [abstract]
Current provisions
931,000 EUR
931,000 EUR
Trade and other current payables
2 411 EUR
1 257 EUR
Current liabilities
3 598 EUR
3 466 EUR
Equity and liabilities
10 288 EUR
10 249 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.